Skip to main content
. 2010 Jul 15;1(1):114–125. doi: 10.1364/BOE.1.000114

Fig. 5.

Fig. 5

Advancement of ICG in the affected arms of 3 lymphedema subjects after PCD treatment. In two subjects, BCRL 4 and 5, ICG is not present above the elbow pre-treatment (A and B, respectively), whereas the ICG has advanced past the elbow and into the upper arm post-treatment (D and E). In another subject, BCRL 6, prior to treatment (C), the ICG is present only at the injection site, and after treatment (F), the ICG has spread proximally through the arm.